Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial.

Wang H, Wang G, Gao Y, Qu L, Wang H, Deng M, Gao H, Li Y, Yang N, Wang B, Liu R, Ma X, Tao Z, Zhang G, Wang Q, Zhao W, Yu Y, Chen L, Liang L, Wang S, Shao L, Yang T, Cao J, Cao Y, Qin X, Ai J, Zhu H, Zhang W

Open source

DOI
10.1016/j.cmi.2024.10.020
Published
2025 Feb
Container
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmi.2024.10.020,
  title = {Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial.},
  author = {Wang H and Wang G and Gao Y and Qu L and Wang H and Deng M and Gao H and Li Y and Yang N and Wang B and Liu R and Ma X and Tao Z and Zhang G and Wang Q and Zhao W and Yu Y and Chen L and Liang L and Wang S and Shao L and Yang T and Cao J and Cao Y and Qin X and Ai J and Zhu H and Zhang W},
  year = {2025},
  journal = {Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
  doi = {10.1016/j.cmi.2024.10.020},
  url = {https://doi.org/10.1016/j.cmi.2024.10.020}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial.
AU  - Wang H
AU  - Wang G
AU  - Gao Y
AU  - Qu L
AU  - Wang H
AU  - Deng M
AU  - Gao H
AU  - Li Y
AU  - Yang N
AU  - Wang B
AU  - Liu R
AU  - Ma X
AU  - Tao Z
AU  - Zhang G
AU  - Wang Q
AU  - Zhao W
AU  - Yu Y
AU  - Chen L
AU  - Liang L
AU  - Wang S
AU  - Shao L
AU  - Yang T
AU  - Cao J
AU  - Cao Y
AU  - Qin X
AU  - Ai J
AU  - Zhu H
AU  - Zhang W
PY  - 2025
JO  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
DO  - 10.1016/j.cmi.2024.10.020
UR  - https://doi.org/10.1016/j.cmi.2024.10.020
ER  - 

APA

H, W., G, W., Y, G., L, Q., H, W., M, D., H, G., Y, L., N, Y., B, W., R, L., X, M., Z, T., G, Z., Q, W., W, Z., Y, Y., L, C., L, L., S, W., L, S., T, Y., J, C., Y, C., X, Q., J, A., H, Z., & W, Z. (2025). Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2024.10.020

Source records